PCa is a disease of aging prostate tissue that exhibits mitochondrial dysfunction and increased mitochondrial stress (41–43), which activates a protective mechanism in mitochondria termed the UPRmt that is mediated by HSP60 and ClpP. This evidence concerns the gene HSPD1 and posterior cortical atrophy.